DK129004B - Analogifremgangsmåde til fremstilling af 9α-usubstituerede 11β-klor-19-norsteroider af østran- eller 19-norpregnanrækken. - Google Patents
Analogifremgangsmåde til fremstilling af 9α-usubstituerede 11β-klor-19-norsteroider af østran- eller 19-norpregnanrækken.Info
- Publication number
- DK129004B DK129004B DK389767AA DK389767A DK129004B DK 129004 B DK129004 B DK 129004B DK 389767A A DK389767A A DK 389767AA DK 389767 A DK389767 A DK 389767A DK 129004 B DK129004 B DK 129004B
- Authority
- DK
- Denmark
- Prior art keywords
- norpregane
- norsteroids
- estrane
- unsubstituted
- chloro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK483769AA DK131295B (da) | 1966-07-29 | 1969-09-10 | Steroider af østran- eller 19-norpregnanrækken til brug som svangerskabsforebyggende midler. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3427566 | 1966-07-29 | ||
| GB23066/67A GB1202521A (en) | 1966-07-29 | 1966-07-29 | 01beta-CHLORO-19-NOR-STEROIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK129004B true DK129004B (da) | 1974-08-05 |
Family
ID=26256295
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK389767AA DK129004B (da) | 1966-07-29 | 1967-07-28 | Analogifremgangsmåde til fremstilling af 9α-usubstituerede 11β-klor-19-norsteroider af østran- eller 19-norpregnanrækken. |
| DK483769AA DK131295B (da) | 1966-07-29 | 1969-09-10 | Steroider af østran- eller 19-norpregnanrækken til brug som svangerskabsforebyggende midler. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK483769AA DK131295B (da) | 1966-07-29 | 1969-09-10 | Steroider af østran- eller 19-norpregnanrækken til brug som svangerskabsforebyggende midler. |
Country Status (12)
| Country | Link |
|---|---|
| JP (2) | JPS5021469B1 (xx) |
| AT (2) | AT301766B (xx) |
| BE (1) | BE702023A (xx) |
| CH (2) | CH580644A5 (xx) |
| DE (1) | DE1668124B2 (xx) |
| DK (2) | DK129004B (xx) |
| FR (2) | FR1565340A (xx) |
| GB (1) | GB1202521A (xx) |
| IL (1) | IL28411A (xx) |
| NL (1) | NL6710459A (xx) |
| PL (1) | PL79253B1 (xx) |
| SE (2) | SE349025B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1289521A (xx) * | 1969-01-23 | 1972-09-20 | ||
| GB1313659A (en) * | 1969-07-25 | 1973-04-18 | Glaxo Lab Ltd | 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds |
| JPS5090183A (xx) * | 1973-12-14 | 1975-07-19 | ||
| JPS5090184A (xx) * | 1973-12-14 | 1975-07-19 |
-
1966
- 1966-07-29 GB GB23066/67A patent/GB1202521A/en not_active Expired
-
1967
- 1967-07-27 PL PL1967121900A patent/PL79253B1/pl unknown
- 1967-07-28 BE BE702023D patent/BE702023A/xx unknown
- 1967-07-28 DE DE1967G0050758 patent/DE1668124B2/de active Granted
- 1967-07-28 NL NL6710459A patent/NL6710459A/xx unknown
- 1967-07-28 AT AT706867A patent/AT301766B/de not_active IP Right Cessation
- 1967-07-28 AT AT851569A patent/AT311564B/de not_active IP Right Cessation
- 1967-07-28 FR FR1565340D patent/FR1565340A/fr not_active Expired
- 1967-07-28 SE SE10939/67*A patent/SE349025B/xx unknown
- 1967-07-28 CH CH1075067A patent/CH580644A5/xx not_active IP Right Cessation
- 1967-07-28 DK DK389767AA patent/DK129004B/da unknown
- 1967-07-28 IL IL28411A patent/IL28411A/en unknown
- 1967-07-28 JP JP42048203A patent/JPS5021469B1/ja active Pending
- 1967-08-23 FR FR125405A patent/FR7812M/fr not_active Expired
-
1969
- 1969-09-10 DK DK483769AA patent/DK131295B/da unknown
-
1970
- 1970-05-19 SE SE06851/70A patent/SE350488B/xx unknown
- 1970-08-31 JP JP45075642A patent/JPS5224013B1/ja active Pending
-
1975
- 1975-08-15 CH CH1075067A patent/CH584724A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL6710459A (xx) | 1968-01-30 |
| DK131295C (xx) | 1975-11-17 |
| PL79253B1 (xx) | 1975-06-30 |
| GB1202521A (en) | 1970-08-19 |
| FR1565340A (xx) | 1969-05-02 |
| AT301766B (de) | 1972-09-25 |
| JPS5224013B1 (xx) | 1977-06-28 |
| SE350488B (xx) | 1972-10-30 |
| IL28411A (en) | 1972-07-26 |
| FR7812M (xx) | 1970-05-20 |
| CH584724A5 (xx) | 1977-02-15 |
| DK131295B (da) | 1975-06-23 |
| JPS5021469B1 (xx) | 1975-07-23 |
| AT311564B (de) | 1973-11-26 |
| DE1668124B2 (de) | 1976-10-07 |
| DE1668124A1 (de) | 1971-05-06 |
| SE349025B (xx) | 1972-09-18 |
| CH580644A5 (xx) | 1976-10-15 |
| BE702023A (xx) | 1968-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK133618B (da) | Analogifremgangsmåde til fremstilling af 1-hydroxyaryl-2-aminoalkanoler. | |
| DK117896B (da) | Analogifremgangsmåde til fremstilling af 17-estere af 21-desoxyprednisolon. | |
| DK115474B (da) | Analogifremgangsmåde til fremstilling af N-p-chlorbenzoyl-5-fluorcytosin. | |
| DK118877B (da) | Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner. | |
| DK117954B (da) | Fremgangsmåde til fremstilling af 3-amino-2-cyanoacrylamid. | |
| DK124886B (da) | Fremgangsnmåde til fremstilling af 1-hydroxy-benzimidazol-N-oxider. | |
| DK129004B (da) | Analogifremgangsmåde til fremstilling af 9α-usubstituerede 11β-klor-19-norsteroider af østran- eller 19-norpregnanrækken. | |
| DK123414B (da) | Analogifremgangsmåde til fremstilling af pteridiner. | |
| DK120540B (da) | Fremgangsmåde til fremstilling af 17α-alkynyl-17β-acyloxysteroider af androstan- eller estranrækken. | |
| DK115551B (da) | Fremgangsmåde til fremstilling af 6-aminouracil-5-carbonamid-N-sulfonamider. | |
| DK122882B (da) | Fremgangsmåde til fremstilling af kawain eller methysticin. | |
| DK125892B (da) | Analogifremgangsmåde til fremstilling af pteridiner. | |
| DK122275B (da) | Fremgangsmåde til fremstilling af 17α-ætynyl-17β-hydroksysteroider af androstan- eller østranrækken. | |
| DK120344B (da) | Fremgangsmåde til fremstilling af 5-benzyl-pyrimidiner. | |
| DK114063B (da) | Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol. | |
| DK122071B (da) | Analogifremgangsmåde til fremstilling af methylenbutyrylphenoler. | |
| DK127107B (da) | Fremgangsmåde til fremstilling af 17α-propadienyl-17β-hydroxy-steroider. | |
| DK122761B (da) | Analogifremgangsmåde til fremstilling af arylsulfonylurinstofderivater. | |
| DK119830B (da) | Analogifremgangsmåde til fremstilling af arylsulfonylsemicarbazider. | |
| DK126378B (da) | Analogifremgangsmåde til fremstilling af 17α-acyloxy-9α-chlor-11β-hydroxy-progesteroner. | |
| DK114626B (da) | Fremgangsmåde til fremstilling af 2-substitueret-4-amino-5-acylamidometylpyrimidin. | |
| DK131820B (da) | Analogifremgangsmåde til fremstilling af 4-aminoquinazoliner eller 1-aminoisoquinoliner. | |
| DK124401B (da) | Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer. | |
| DK121165B (da) | Fremgangsmåde til fremstilling af 1-aminoalkyl-1-arylindenar eller 3-aminoalkyl-3-arylindan-1-oler. | |
| DK120845B (da) | Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider. |